Roper Technologies (ROP) Sells CIVCO Radiotherapy to Blue Wolf Capital

Go back to Roper Technologies (ROP) Sells CIVCO Radiotherapy to Blue Wolf Capital

Roper Technologies (ROP) Tops Q3 EPS by 8c

October 22, 2021 6:58 AM EDT

Roper Technologies (NYSE: ROP) reported Q3 EPS of $3.91, $0.08 better than the analyst estimate of $3.83. Revenue for the quarter came in at $1.46 billion versus the consensus estimate of $1.61 billion.

GUIDANCE:

Roper Technologies sees FY2021 EPS of $15.26-$15.30, versus the consensus of... More

Roper Technologies (ROP) to Divest CIVCO Radiotherapy

October 22, 2021 6:56 AM EDT

Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, today announced that it has reached a definitive agreement to sell its CIVCO Radiotherapy business to an affiliate of Blue Wolf Capital Partners LLC, a private equity firm, in an all-cash transaction valued at... More